JAGX
Jaguar Animal Health Inc
NASDAQ: JAGX · HEALTHCARE · BIOTECHNOLOGY
$6.96
+2993.33% today
Updated 2026-04-30
Market cap
$3.65M
P/E ratio
—
P/S ratio
0.32x
EPS (TTM)
$-22.97
Dividend yield
—
52W range
$0 – $13
Volume
0.6M
Jaguar Animal Health Inc (JAGX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $303297.00 | $0.00 | $258381.00 | $141523.00 | $4.36M | $4.42M | $5.78M | $9.38M | $4.33M | $11.96M | $9.76M | $11.69M | $11.51M |
| Revenue growth (YoY) | — | -100.0% | — | -45.2% | +2981.6% | +1.3% | +30.8% | +62.5% | -53.8% | +175.8% | -18.4% | +19.8% | -1.5% |
| Cost of revenue | $0.00 | $1.40M | $123457.00 | $51966.00 | $880405.00 | $2.77M | $3.82M | $3.28M | $2.33M | $2.02M | $2.04M | $1.96M | $3.77M |
| Gross profit | $303297.00 | $0.00 | $134924.00 | $89557.00 | $3.48M | $1.65M | $1.96M | $6.11M | $2.00M | $9.94M | $7.72M | $9.73M | $7.74M |
| Gross margin | 100.0% | — | 52.2% | 63.3% | 79.8% | 37.4% | 33.9% | 65.1% | 46.2% | 83.1% | 79.1% | 83.3% | 67.2% |
| R&D | $15.40M | $4.22M | $6.48M | $7.21M | $4.27M | $5.15M | $5.82M | $6.41M | $15.08M | $17.65M | $18.60M | $16.54M | $24.97M |
| SG&A | $7.05M | $4.10M | $5.34M | $5.98M | $11.25M | $12.28M | $13.50M | $14.39M | $17.10M | $17.87M | $16.59M | $16.33M | $18.64M |
| Operating income | $-22.15M | $-8.32M | $-12.45M | $-13.59M | $-34.25M | $-30.82M | $-28.95M | $-26.65M | $-40.71M | $-34.41M | $-34.29M | $-30.83M | $-45.91M |
| Operating margin | -7303.7% | — | -4816.7% | -9599.8% | -785.3% | -698.0% | -501.3% | -283.9% | -939.1% | -287.8% | -351.3% | -263.8% | -398.8% |
| EBITDA | — | $-8.37M | $-12.97M | $-13.70M | $-11.13M | $-27.77M | $-30.87M | $-28.74M | $-42.37M | $-33.38M | $-32.76M | $-36.66M | $-45.91M |
| EBITDA margin | 0.0% | — | -5019.4% | -9680.9% | -255.2% | -628.8% | -534.5% | -306.2% | -977.3% | -279.2% | -335.6% | -313.6% | -398.8% |
| EBIT | $-22.15M | $-8.32M | $-12.97M | $-13.75M | $-11.72M | $-29.52M | $-32.80M | $-31.02M | $-44.18M | $-35.67M | $-33.92M | $-39.02M | $-37.90M |
| Interest expense | $0.00 | $0.00 | $3.32M | $985549.00 | $1.21M | $2.63M | $5.73M | $2.79M | $8.42M | $12.72M | $6.38M | $231000.00 | $67000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-25.53M | $-8.61M | $-16.29M | $-14.73M | $-21.97M | $-32.15M | $-38.54M | $-33.81M | $-52.59M | $-47.45M | $-41.30M | $-38.49M | $-53.58M |
| Net income growth (YoY) | — | +66.3% | -89.2% | +9.6% | -49.1% | -46.3% | -19.9% | +12.3% | -55.6% | +9.8% | +13.0% | +6.8% | -39.2% |
| Profit margin | -8416.4% | — | -6305.2% | -10410.9% | -503.7% | -727.9% | -667.3% | -360.2% | -1213.3% | -396.9% | -423.1% | -329.3% | -465.4% |